Page last updated: 2024-10-27

foscarnet and Hyponatremia

foscarnet has been researched along with Hyponatremia in 3 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Hyponatremia: Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
" Although prompt treatment with foscarnet stabilized encephalitis and there were no serious neurological sequelae, the patient developed both hyponatremia and natriuresis 11 days after intravenous administration of foscarnet."3.74[Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant]. ( Akiyama, H; Ando, M; Koshida, A; Najima, Y; Ohashi, K; Sakamaki, H; Yamashita, T, 2008)
"Foscarnet was restarted and continued until day +269 UCBT due to multiple HHV-6 recurrences with persistent hyponatremia."1.91Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient. ( Gannamani, V; Nathan, S; Ustun, C; Varma, A, 2023)
"Treatment with foscarnet sodium and hypertonic saline was started with improvement of neurological condition within several days."1.39Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation. ( Abe, D; Iseki, T; Kawaguchi, T; Kawajiri, C; Nagao, Y; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, N; Sugita, Y; Takeda, Y; Takeuchi, M; Tsukamoto, S; Yamazaki, A; Yokote, K, 2013)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Gannamani, V1
Varma, A1
Nathan, S1
Ustun, C1
Kawaguchi, T1
Takeuchi, M1
Kawajiri, C1
Abe, D1
Nagao, Y1
Yamazaki, A1
Sugita, Y1
Tsukamoto, S1
Sakai, S1
Takeda, Y1
Ohwada, C1
Sakaida, E1
Shimizu, N1
Yokote, K1
Iseki, T1
Nakaseko, C1
Najima, Y1
Ohashi, K1
Ando, M1
Koshida, A1
Yamashita, T1
Akiyama, H1
Sakamaki, H1

Other Studies

3 other studies available for foscarnet and Hyponatremia

ArticleYear
Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.
    Transplant immunology, 2023, Volume: 76

    Topics: Cord Blood Stem Cell Transplantation; Female; Foscarnet; Herpesvirus 6, Human; Humans; Hyponatremia;

2023
Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:2

    Topics: Antiviral Agents; Bone Marrow Transplantation; Diagnosis, Differential; DNA, Viral; Female; Foscarne

2013
[Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2008, Volume: 49, Issue:1

    Topics: Antiviral Agents; Encephalitis, Viral; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; H

2008